Trilink Biotechnologies, LLC
Records under this name other than the patents Trilink Biotechnologies, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Back to Trilink Biotechnologies, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,846,875 | Preparation and/or Purification of Oligonucleotide Conjugates Formerly held In force · High confidence | In force | High confidence | |
| US 8,541,555 | Novel Hydrazone-Based and Oxime-Based Fluorescent and Chromophoric/Pro-Fluorescent and Pro-Chromophoric Reagents and Linkers Formerly held In force · High confidence | In force | High confidence | |
| US 8,728,725 | Chemically Modified Ligase Cofactors, Donors and Acceptors Lapsed on the fee record Ended May 20, 2026 · High confidence | Lapsed on the fee record | Ended May 20, 2026 | High confidence |
| US 9,631,227 | Chemically Modified Ligase Cofactors, Donors and Acceptors Lapsed on the fee record Ended Apr 25, 2025 · High confidence | Lapsed on the fee record | Ended Apr 25, 2025 | High confidence |
| US RE46,171 | Functional Biopolymer Modification Reagents and Uses Thereof Formerly held Term ended Term ended Oct 2, 2024 · Low confidence | Term ended | Term ended Oct 2, 2024 | Low confidence |
| US 7,102,024 | Functional biopolymer modification reagents and uses thereof Formerly held Term ended Term ended Sep 6, 2023 · USPTO record | Term ended | Term ended Sep 6, 2023 | USPTO record |
| US 7,999,098 | Triphosphate Oligonucleotide Modification Reagents and Uses Thereof Formerly held Lapsed on the fee record Ended Aug 16, 2023 · Low confidence | Lapsed on the fee record | Ended Aug 16, 2023 | Low confidence |
| US 6,911,535 | Biomolecule/Polymer Conjugates Formerly held Term ended Term ended Mar 31, 2022 · High confidence | Term ended | Term ended Mar 31, 2022 | High confidence |
| US 7,173,125 | Triphosphate Oligonucleotide Modification Reagents and Uses Thereof Formerly held Term ended Term ended Jan 29, 2022 · Medium confidence | Term ended | Term ended Jan 29, 2022 | Medium confidence |
| US 7,462,689 | Hydrazine-Based and Carbonyl-Based Bifunctional Crosslinking Reagents Formerly held Term ended Term ended Jul 15, 2021 · High confidence | Term ended | Term ended Jul 15, 2021 | High confidence |